Economic and Psychological Evaluation of the Multi-Centre Aneurysm Screening study (MASS)
Objectives: To assess the impact upon quality of life for men and their partners who are invited to participate in Abdominal Aortic Aneurysm (AAA) screening. To assess the impact of the screening programme and treatment on NHS and patient costs.
Methods: Quality of life will be measured using the SF36 and the EuroQol. In addition, anxiety and depression will be measured using questions from the Hospital Anxiety and Depression Scale (HADS), the State-Trait Anxiety Inventory (STAI) and the Life Orientation Test (LOT). A sample of patients who decline the invitation to attend the screening programme, screened negative patients and control patients will be requested to complete the questionnaire once. All screened positive patients and surgery patients will be requested to complete the questionnaire at intervals until 12 months post-screening or post-surgery. Retrospective data relating to resource-use/costs will be collected on 300 patients who undergo an elective AAA repair and 200 patients who undergo an emergency AAA repair.
Main collaborators: Mr Alan Scott (St. Richard’s Hospital, Chichester), Professor Nick Day (MRC Bio statistics unit) Mr Gareth Morris (Southampton General Hospital), Mr Graham Sutton (Queen Alexandra Hospital, Portsmouth), Mr Jack Collin (John Radcliffe Hospital, Oxford), Mr Nick Wilson (Royal Hampshire County Hospital, Winchester).